Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies

Graham Fairfoul; Lynne I McGuire; Suvankar Pal; James W Ironside; Juliane Neumann; Sharon Christie; Catherine Joachim; Margaret Esiri; Samuel G Evetts; Michal Rolinski; Fahd Baig; Claudio Ruffmann; Richard Wade-Martins; Michele T M Hu; Laura Parkkinen; Alison J E Green

doi:10.1002/acn3.338

Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies

Graham Fairfoul
, Lynne I McGuire
, Suvankar Pal
, James W Ironside
, Juliane Neumann
, Sharon Christie
, Catherine Joachim
, Margaret Esiri
, Samuel G Evetts
, Michal Rolinski
, Fahd Baig
, Claudio Ruffmann
, Richard Wade-Martins
, Michele T M Hu
, Laura Parkkinen
, Alison J E Green

Research output: Contribution to journal › Article (Academic Journal) › peer-review

528 Citations (Scopus)

349 Downloads (Pure)

Abstract

We have developed a novel real-time quaking-induced conversion RT-QuIC-based assay to detect alpha-synuclein aggregation in brain and cerebrospinal fluid from dementia with Lewy bodies and Parkinson's disease patients. This assay can detect alpha-synuclein aggregation in Dementia with Lewy bodies and Parkinson's disease cerebrospinal fluid with sensitivities of 92% and 95%, respectively, and with an overall specificity of 100% when compared to Alzheimer and control cerebrospinal fluid. Patients with neuropathologically confirmed tauopathies (progressive supranuclear palsy; corticobasal degeneration) gave negative results. These results suggest that RT-QuiC analysis of cerebrospinal fluid is potentially useful for the early clinical assessment of patients with alpha-synucleinopathies.

Original language	English
Pages (from-to)	812-818
Number of pages	7
Journal	Annals of Clinical and Translational Neurology
Volume	3
Issue number	10
Early online date	28 Aug 2016
DOIs	https://doi.org/10.1002/acn3.338
Publication status	Published - Oct 2016

Access to Document

10.1002/acn3.338

Full-text PDF (final published version)Final published version, 736 KBLicence: CC BY

Handle.net

Persistent link

Cite this

Fairfoul, G., McGuire, L. I., Pal, S., Ironside, J. W., Neumann, J., Christie, S., Joachim, C., Esiri, M., Evetts, S. G., Rolinski, M., Baig, F., Ruffmann, C., Wade-Martins, R., Hu, M. T. M., Parkkinen, L., & Green, A. J. E. (2016). Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Annals of Clinical and Translational Neurology, 3(10), 812-818. https://doi.org/10.1002/acn3.338

@article{ad7fdf4265e84adaa4e6dc2b03ce0686,

title = "Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies",

abstract = "We have developed a novel real-time quaking-induced conversion RT-QuIC-based assay to detect alpha-synuclein aggregation in brain and cerebrospinal fluid from dementia with Lewy bodies and Parkinson's disease patients. This assay can detect alpha-synuclein aggregation in Dementia with Lewy bodies and Parkinson's disease cerebrospinal fluid with sensitivities of 92\% and 95\%, respectively, and with an overall specificity of 100\% when compared to Alzheimer and control cerebrospinal fluid. Patients with neuropathologically confirmed tauopathies (progressive supranuclear palsy; corticobasal degeneration) gave negative results. These results suggest that RT-QuiC analysis of cerebrospinal fluid is potentially useful for the early clinical assessment of patients with alpha-synucleinopathies.",

author = "Graham Fairfoul and McGuire, \{Lynne I\} and Suvankar Pal and Ironside, \{James W\} and Juliane Neumann and Sharon Christie and Catherine Joachim and Margaret Esiri and Evetts, \{Samuel G\} and Michal Rolinski and Fahd Baig and Claudio Ruffmann and Richard Wade-Martins and Hu, \{Michele T M\} and Laura Parkkinen and Green, \{Alison J E\}",

year = "2016",

month = oct,

doi = "10.1002/acn3.338",

language = "English",

volume = "3",

pages = "812--818",

journal = "Annals of Clinical and Translational Neurology",

issn = "2328-9503",

publisher = "John Wiley \& Sons, Inc",

number = "10",

}

Fairfoul, G, McGuire, LI, Pal, S, Ironside, JW, Neumann, J, Christie, S, Joachim, C, Esiri, M, Evetts, SG, Rolinski, M, Baig, F, Ruffmann, C, Wade-Martins, R, Hu, MTM, Parkkinen, L & Green, AJE 2016, 'Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies', Annals of Clinical and Translational Neurology, vol. 3, no. 10, pp. 812-818. https://doi.org/10.1002/acn3.338

TY - JOUR

T1 - Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies

AU - Fairfoul, Graham

AU - McGuire, Lynne I

AU - Pal, Suvankar

AU - Ironside, James W

AU - Neumann, Juliane

AU - Christie, Sharon

AU - Joachim, Catherine

AU - Esiri, Margaret

AU - Evetts, Samuel G

AU - Rolinski, Michal

AU - Baig, Fahd

AU - Ruffmann, Claudio

AU - Wade-Martins, Richard

AU - Hu, Michele T M

AU - Parkkinen, Laura

AU - Green, Alison J E

PY - 2016/10

Y1 - 2016/10

N2 - We have developed a novel real-time quaking-induced conversion RT-QuIC-based assay to detect alpha-synuclein aggregation in brain and cerebrospinal fluid from dementia with Lewy bodies and Parkinson's disease patients. This assay can detect alpha-synuclein aggregation in Dementia with Lewy bodies and Parkinson's disease cerebrospinal fluid with sensitivities of 92% and 95%, respectively, and with an overall specificity of 100% when compared to Alzheimer and control cerebrospinal fluid. Patients with neuropathologically confirmed tauopathies (progressive supranuclear palsy; corticobasal degeneration) gave negative results. These results suggest that RT-QuiC analysis of cerebrospinal fluid is potentially useful for the early clinical assessment of patients with alpha-synucleinopathies.

AB - We have developed a novel real-time quaking-induced conversion RT-QuIC-based assay to detect alpha-synuclein aggregation in brain and cerebrospinal fluid from dementia with Lewy bodies and Parkinson's disease patients. This assay can detect alpha-synuclein aggregation in Dementia with Lewy bodies and Parkinson's disease cerebrospinal fluid with sensitivities of 92% and 95%, respectively, and with an overall specificity of 100% when compared to Alzheimer and control cerebrospinal fluid. Patients with neuropathologically confirmed tauopathies (progressive supranuclear palsy; corticobasal degeneration) gave negative results. These results suggest that RT-QuiC analysis of cerebrospinal fluid is potentially useful for the early clinical assessment of patients with alpha-synucleinopathies.

U2 - 10.1002/acn3.338

DO - 10.1002/acn3.338

M3 - Article (Academic Journal)

C2 - 27752516

SN - 2328-9503

VL - 3

SP - 812

EP - 818

JO - Annals of Clinical and Translational Neurology

JF - Annals of Clinical and Translational Neurology

IS - 10

ER -

Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies

Abstract

Access to Document

Handle.net

Fingerprint

Cite this